"Radiation oncology; 3D conventional; IMRT; IGRT; High dose rate brachytherapy; Low dose rate brachytherapy for prostate; Medical oncology; Infusional therapy to include chemotherapy, hydration, and other medication"

During the past decade, Geisinger Medical Oncology-Lewisburg conducted 122 clinical trials. In the 10-year time frame, 122 clinical trials started and 47 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 42 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Geisinger Medical Oncology-Lewisburg" #1 sponsor was "National Cancer Institute (NCI)" with 68 trials, followed by "SWOG Cancer Research Network" with 23 trials sponsored, "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "NRG Oncology" with 16 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Geisinger Medical Oncology-Lewisburg" #1 collaborator was "National Cancer Institute (NCI)" with 81 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Biologics, Inc." with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Geisinger Medical Oncology-Lewisburg" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IIIA Breast Cancer" (6 trials), "HER2/Neu Negative" (5 trials) and "Invasive Breast Carcinoma" (5 trials). Many other conditions were trialed in "Geisinger Medical Oncology-Lewisburg" in a lesser frequency.

Most popular intervention types in "Geisinger Medical Oncology-Lewisburg" are "Drug" (113 trials), "Other" (102 trials), "Biological" (58 trials), "Procedure" (40 trials) and "Radiation" (37 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Quality-of-Life Assessment" (45 trials), "Questionnaire Administration" (29 trials), "Computed Tomography" (24 trials) and "Cisplatin" (22 trials). Other intervention names were less common.

The vast majority of trials in "Geisinger Medical Oncology-Lewisburg" are 122 trials for "All" genders, 22 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Geisinger Medical Oncology-Lewisburg". undefined are not yet recruiting, 45 are recruiting, 71 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Geisinger Medical Oncology-Lewisburg, 7 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Geisinger Medical Oncology-Lewisburg, 4 "Phase 1" clinical trials were conducted, 78 "Phase 2" clinical trials and 80 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".